Charles Schwab Investment Management Inc Cytosorbents Corp Transaction History

Charles Schwab Investment Management Inc

$429 Billion
Q1 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 08, 2023	SELL	$1.86 - $4.03 $930 - $2,015	-500 Reduced 3.03%	15,994 $30,000
Q2 2023 Aug 09, 2023	BUY	$2.37 - $3.65 $1,185 - $1,825	500 Added 3.13%	16,494 $59,000
Q2 2022 Aug 15, 2022	SELL	$1.76 - $3.22 $157,870 - $288,830	-89,699 Reduced 84.87%	15,994 $36,000
Q1 2022 May 13, 2022	BUY	$2.88 - $4.23 $1,618 - $2,377	562 Added 0.53%	105,693 $338,000
Q4 2021 Feb 11, 2022	BUY	$4.05 - $8.11 $9,124 - $18,271	2,253 Added 2.19%	105,131 $441,000

Q3 2021 Nov 16, 2021	SELL	$7.0 - $9.71 $3,626 - $5,029	-518 Reduced 0.5%	102,878 $836,000
Q2 2021 Aug 16, 2021	SELL	$7.55 - $9.42 $7,519 - $9,382	-996 Reduced 0.95%	103,396 $781,000
Q1 2021 May 17, 2021	BUY	$8.23 - $11.48 $25,619 - $35,737	3,113 Added 3.07%	104,392 $907,000
Q4 2020 Feb 16, 2021	BUY	$7.65 - $8.98 $48,080 - $56,439	6,285 Added 6.62%	101,279 $808,000
Q3 2020 Nov 13, 2020	BUY	$7.37 - $11.54 $80,436 - $125,947	10,914 Added 12.98%	94,994 $758,000
Q2 2020 Aug 14, 2020	BUY	$6.28 - $10.59 $18,205 - $30,700	2,899 Added 3.57%	84,080 $833,000
Q4 2019 Feb 07, 2020	SELL	$3.61 - $5.22 $20,515 - $29,665	-5,683 Reduced 6.54%	81,181 $313,000
Q3 2019 Nov 08, 2019	BUY	$4.33 - $7.63 $24,222 - $42,682	5,594 Added 6.88%	86,864 $437,000
Q2 2019 Aug 09, 2019	BUY	$5.92 - $7.78 $115,078 - $151,235	19,439 Added 31.44%	81,270 $538,000
Q1 2019 May 14, 2019	SELL	$6.82 - $8.56 $9,016 - $11,316	-1,322 Reduced 2.09%	61,831 $469,000
Q4 2018 Feb 14, 2019	BUY	$7.05 - $12.64 $5,139 - $9,214	729 Added 1.17%	63,153 $511,000
Q3 2018 Nov 13, 2018	BUY	$10.95 - $14.8 $28,765 - $38,879	2,627 Added 4.39%	62,424 $806,000
Q2 2018 Aug 08, 2018	BUY	$6.9 - $12.35 $412,599 - $738,492	59,797 New	59,797 $682,000

Others Institutions Holding CTSO

# of Institutions

Shares Held

17.8M

Call Options Held

Put Options Held

Avenir Corp Washington, DC

3.17M
Shares

$2.89 Million
0.27% of portfolio
Granahan Investment Management, LLC Waltham, MA

3.04M
Shares

$2.77 Million
0.1% of portfolio
Skylands Capital, LLC

2.88M
Shares

$2.62 Million
0.4% of portfolio
Vanguard Group Inc Valley Forge, PA

1.95M
Shares

$1.77 Million
0.0% of portfolio
Neuberger Berman Group LLC New York, NY

1.91M
Shares

$1.74 Million
0.0% of portfolio

View Full List

About Cytosorbents Corp

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $39.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

More about CTSO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account